<DOC>
	<DOC>NCT00336557</DOC>
	<brief_summary>An observational study to determine the impact of multiple neutralizing antibody (NAb) tests on treatment patterns compared to the usual care of MS patients receiving high-dose IFN therapy.</brief_summary>
	<brief_title>Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy</brief_title>
	<detailed_description>An observational study to determine the impact of multiple neutralizing antibody (NAb) tests on treatment patterns compared to the usual care of MS patients receiving high-dose IFN therapy.</detailed_description>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<criteria>Willing to provide informed consent. Male or female, 18 years of age or older, with a diagnosis of MS. Has been on oral or parenteral corticosteroid therapy within the two weeks prior to the Baseline Visit. Has been treated with immunoglobulins (IgG) or plasmapheresis within the last six months. Has any condition which the investigator or nurse feels may interfere with participation in the study or with assessments for the full duration of the study. Previously participated in this study. Has received an experimental drug in the last thirty (30) days.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>High-Dose Interferon</keyword>
	<keyword>Neutralizing Antibodies</keyword>
</DOC>